Par Drugs and Chemicals Limited
PAR.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.44B
Close$
Share Statistics
| Market cap | $1.44 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $10.65 |
| Beta | 0.1 |
| Outstanding Shares | 12,304,636 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 9.94 |
|---|---|
| PEG | 23.89 |
| Price to Sales | 1.33 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Par Drugs and Chemicals Limited
118 employees
CEO: Jignesh Vallabhbhai Savani Par Drugs and Chemicals Limited is an Indian enterprise that focuses on the creation, production, and sale of active pharmaceutical ingredients (APIs) and specialized chemicals. Its comprehensive product line features a diverse array of ...